Gilead Sciences to Present at Upcoming Investor Conference

Rhea-AI Summary

Gilead Sciences, Inc. (Nasdaq: GILD) executives to speak at J.P. Morgan Healthcare Conference on January 8, 2024

FOSTER CITY, Calif.--(BUSINESS WIRE)-- Gilead Sciences, Inc. (Nasdaq: GILD) announced today that its executives will be speaking at the following investor conference:

J.P. Morgan Healthcare Conference on Monday, January 8, 2024 beginning at 10:30 a.m. Pacific Time

The live webcast can be accessed at the company’s investors page at investors.gilead.com. The replay will be available for at least 30 days following the presentation.

About Gilead Sciences

Gilead Sciences, Inc. is a biopharmaceutical company that has pursued and achieved breakthroughs in medicine for more than three decades, with the goal of creating a healthier world for all people. The company is committed to advancing innovative medicines to prevent and treat life-threatening diseases, including HIV, viral hepatitis and cancer. Gilead operates in more than 35 countries worldwide, with headquarters in Foster City, California.

For more information on Gilead Sciences, please visit the company’s website at www.gilead.com, follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs at 1-800-GILEAD-5 or 1-650-574-3000.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231221812128/en/

Jacquie Ross, Investors

Investor_relations@gilead.com

Source: Gilead Sciences, Inc.

FAQ

When is Gilead Sciences, Inc. executives speaking at the J.P. Morgan Healthcare Conference?

Gilead Sciences, Inc. executives will be speaking at the J.P. Morgan Healthcare Conference on Monday, January 8, 2024 beginning at 10:30 a.m. Pacific Time.

Where can the live webcast be accessed?

The live webcast can be accessed at the company’s investors page at investors.gilead.com.

How long will the replay be available?

The replay will be available for at least 30 days following the presentation.